Stent Comparison Study With Vitamin C for Heart Disease
Part of Heart & circulation clinical trials.
This trial compares two drug-coated stents for treating blocked heart arteries, with or without vitamin C (ascorbic acid). It tests whether sirolimus plus vitamin C is as safe and effective as everolimus. If you need a stent, this study may help determine which medication coating works best for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 19 years old.
- You must have heart disease (chronic or acute) and be scheduled for a stent procedure to open blocked arteries.
- You must be able to take two blood-thinning medications (aspirin and a P2Y12 inhibitor like clopidogrel) for one year after the procedure.
- You must not have had cardiogenic shock (a severe form of heart failure) within 48 hours before the procedure.
- You must not be allergic to sirolimus, everolimus, or ascorbic acid, or to the stent materials (cobalt-chromium).
- Women who can become pregnant must have a negative pregnancy test and agree to use contraception during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.